Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Mazzarella

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
American Journal of Human Genetics|March 24, 2021
Machine learning-based reclassification of germline variants of unknown significance: The RENOVO algorithmValentina Favalli, Giulia Tini, Emanuele Bonetti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A reviewLuca Mazzarella, Bruno Achutti Duso, Dario Trapani, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2013
Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patientsLuca Mazzarella, Davide Disalvatore, Vincenzo Bagnardi, et al.
Frontiers in Medicine|July 23, 2020
Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair InformativenessGiulia Tini, Bruno Achutti Duso, Federica Bellerba, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Liver toxicity in the era of immune checkpoint inhibitors: A practical approachCarmen Belli, Massimo Zuin, Luca Mazzarella, et al.
Genome Medicine|February 19, 2015
DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomesGiorgio Em Melloni, Alessandro Ge Ogier, Stefano de Pretis, et al.
Cancers|July 9, 2022
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor BoardsEdoardo Crimini, Matteo Repetto, Paolo Tarantino, et al.
Breast Cancer Research : BCR|June 2, 2017
A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer dataGiorgio E M Melloni, Luca Mazzarella, Loris Bernard, et al.
Science Advances|October 13, 2016
Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in miceAlessandra Rossi, Karin J Ferrari, Andrea Piunti, et al.
Bioorganic & Medicinal Chemistry|March 7, 2013
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in Pt(II) complexes on human carcinoma cell lines: a comparative study with cisplatinNicola Ferri, Stefano Cazzaniga, Luca Mazzarella, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
American Journal of Human Genetics|March 24, 2021
Machine learning-based reclassification of germline variants of unknown significance: The RENOVO algorithmValentina Favalli, Giulia Tini, Emanuele Bonetti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A reviewLuca Mazzarella, Bruno Achutti Duso, Dario Trapani, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2013
Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patientsLuca Mazzarella, Davide Disalvatore, Vincenzo Bagnardi, et al.
Frontiers in Medicine|July 23, 2020
Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair InformativenessGiulia Tini, Bruno Achutti Duso, Federica Bellerba, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Liver toxicity in the era of immune checkpoint inhibitors: A practical approachCarmen Belli, Massimo Zuin, Luca Mazzarella, et al.
Genome Medicine|February 19, 2015
DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomesGiorgio Em Melloni, Alessandro Ge Ogier, Stefano de Pretis, et al.
Cancers|July 9, 2022
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor BoardsEdoardo Crimini, Matteo Repetto, Paolo Tarantino, et al.
Breast Cancer Research : BCR|June 2, 2017
A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer dataGiorgio E M Melloni, Luca Mazzarella, Loris Bernard, et al.
Science Advances|October 13, 2016
Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in miceAlessandra Rossi, Karin J Ferrari, Andrea Piunti, et al.
Bioorganic & Medicinal Chemistry|March 7, 2013
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in Pt(II) complexes on human carcinoma cell lines: a comparative study with cisplatinNicola Ferri, Stefano Cazzaniga, Luca Mazzarella, et al.
Pageof 9